about
MicroRNAs in Drug-induced Liver InjuryChinese Herbal Medicine-induced Liver InjuryEvaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicityEnhancement of CYP3A4 activity in Hep G2 cells by lentiviral transfection of hepatocyte nuclear factor-1 alphaCost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study.Clinical hepatotoxicity associated with antifungal agents.Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial.Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.Analgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study.Study of arsenic accumulation in rice and evaluation of protective effects of Chorchorus olitorius leaves against arsenic contaminated rice induced toxicities in Wistar albino ratsMethimazole associated eosinophilic pleural effusion: a case report.ATT- A Double Edged Sword?Methimazole-induced cholestatic hepatitis: two cases report and literature reviewDrug metabolism alterations in nonalcoholic fatty liver diseaseLiver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure: A Case Report and Review of the Literature.Rechallenge in drug-induced liver injury: the attractive hazard.Biomarkers for drug-induced liver injury.Predicting and preventing acute drug-induced liver injury: what's new in 2010?In silico models for drug-induced liver injury--current status.The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury.Hormonal regulation of hepatic drug biotransformation and transport systems.miRNAs and their application in drug-induced liver injury.Liver injury associated with ketoconazole: review of the published evidence.Drug safety assessment of oral formulations of ketoconazole.Development and regulatory application of microRNA biomarkers.Mechanism of Hepatocyte Apoptosis.The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury.An unusual cause of febrile hepatitis.Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study.Effect of moderate liver impairment on the pharmacokinetics of opicapone.Drug-induced liver injury in the Australian setting.Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity.Evaluation of Bacillus subtilis SPB1 biosurfactant effects on hyperglycemia, angiotensin I-converting enzyme (ACE) activity and kidney function in rats fed on high-fat-high-fructose diet.In vitro antioxidant and hepatoprotective potential of Azolla microphylla phytochemically synthesized gold nanoparticles on acetaminophen - induced hepatocyte damage in Cyprinus carpio L.Hepato- and neuro-protective influences of biopropolis on thioacetamide-induced acute hepatic encephalopathy in rats.The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.Three-dimensional microtissues as an in vitro model for personalized radiation therapy.Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation.
P2860
Q26781801-AB771186-7E7D-4913-A39D-EDEA8873ED5CQ26781971-2A670F1F-D2BB-4DB4-85CA-BD945868244FQ27027301-FE0CA93B-636D-4869-9AB4-72EBFB2BA9F5Q28537869-F09B0A3E-C7EE-471F-95CD-F4867372FFD7Q34281346-5F25D2F4-3865-41D3-A203-8B8D363D1A05Q34308029-D984F069-4692-4B5B-8187-4A82189151C0Q34546811-B33519C5-A32B-47E9-9CBB-7A802A82B3E9Q34978897-A45116F0-159F-49DB-BEDF-F20B415917A0Q35232798-F0251054-96CC-4D9A-9A32-B2F3D79A262DQ35654986-2C0CE41F-3897-45EF-8345-6BC4CFDB7FA2Q36163209-BCB125EC-3216-4A29-8901-3D4EFED3BCCBQ36315503-9122A1D1-48EC-4776-9A5B-06E39D0B8A0BQ36346007-616F3167-09D9-4ABD-B9BC-E241F98B3D29Q36782685-9A37277B-060F-42B8-A74D-A7EF51E2D112Q37120909-E47B1062-AA3F-4B46-9A8B-552591CFDC39Q37225859-E6E5B0E2-29B6-41D9-B9AB-361573222FEEQ37646772-8990B796-3DA9-4971-8E35-182A316B464AQ37720754-FC1D951A-9227-4BA4-BC68-7643AFB3B065Q37771029-E8305040-906C-44CE-8AC2-9C3A41BF2C9DQ37976120-1A808301-1A95-4EC1-BC00-1D616792A2CCQ37979858-AB266ABC-FCEF-4824-AFB4-6EF636CDDAA1Q38095111-39B7111B-CF29-46A5-8132-66813B5458F5Q38165145-1AB3307B-5A60-4669-96E5-F9C4E04707E2Q38187448-6700DE93-4275-47D2-9A1B-42CC6B98E0ABQ38248677-A1B35C76-8149-41FA-A34F-B95E36DECAEAQ38269550-D762BE04-DF94-4CC6-B0C8-8D2E57453C6BQ38616581-884A4C48-79D9-4BB2-AEC6-F55193F6E58BQ38774266-659BF363-D81C-4B2B-AE1A-A86264DCB159Q38782421-8F004304-6901-4FE2-8C6F-8CDD4B4A8AEAQ40149987-30062E4F-B980-45A0-901F-334F195EC9CCQ41117405-1EEF67F4-7241-4D19-9C75-9F1CCB3B82F3Q42629887-176B395A-5F1B-44FC-B28A-76F79A482A74Q43424045-9A72EAA7-C3D6-488D-86D3-462435B0BEDFQ44947668-FC1AFAE1-4CEF-4E95-B365-02C21270A46FQ46494784-B4A5D49D-F1AE-4468-BE71-E4A37FB51532Q46745408-89DAE2B7-0F5F-46D5-ACA4-D0FF012901D1Q46863732-D82EA751-AEBE-4646-B57E-3CE78EA4432EQ47159298-9205F455-EE0B-4822-B162-9FF8D7F84365Q47790954-237D1317-C2EC-47B0-9E3E-106816B68479Q51638519-3FE1512A-C8F9-41EF-805D-372EF40E2FAF
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Drug-induced liver injury: is it somehow foreseeable?
@en
Drug-induced liver injury: is it somehow foreseeable?
@nl
type
label
Drug-induced liver injury: is it somehow foreseeable?
@en
Drug-induced liver injury: is it somehow foreseeable?
@nl
prefLabel
Drug-induced liver injury: is it somehow foreseeable?
@en
Drug-induced liver injury: is it somehow foreseeable?
@nl
P2860
P356
P1476
Drug-induced liver injury: is it somehow foreseeable?
@en
P2093
Domenico Capone
Giovanni Tarantino
P2860
P304
P356
10.3748/WJG.15.2817
P407
P577
2009-06-01T00:00:00Z